According to the latest data from the Hong Kong Stock Exchange, on May 8, UBS Group AG increased its holdings of Chinese Traditional Chinese Medicine (00570.HK) by 30 million shares, at a price of HK$43,108 per share, for a total amount of about HK$129 million. After the increase in holdings, the latest number of shares held was approximately 313 million shares, and the latest shareholding ratio was 6.21%.
UBS Group AG增持中国中药(00570.HK)3000万股 每股作价4.31港元
UBS Group AG increased its holdings of Chinese Traditional Chinese Medicine (00570.HK) by 30 million shares at HK$4.31 per share
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.